Laurent Devel

2.1k total citations · 1 hit paper
43 papers, 1.4k citations indexed

About

Laurent Devel is a scholar working on Oncology, Cancer Research and Molecular Biology. According to data from OpenAlex, Laurent Devel has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 26 papers in Cancer Research and 23 papers in Molecular Biology. Recurrent topics in Laurent Devel's work include Protease and Inhibitor Mechanisms (26 papers), Peptidase Inhibition and Analysis (23 papers) and Chemical Synthesis and Analysis (5 papers). Laurent Devel is often cited by papers focused on Protease and Inhibitor Mechanisms (26 papers), Peptidase Inhibition and Analysis (23 papers) and Chemical Synthesis and Analysis (5 papers). Laurent Devel collaborates with scholars based in France, Greece and United States. Laurent Devel's co-authors include Vincent Dive, Fabrice Beau, Bertrand Czarny, Athanasios Yiotakis, Dimitris Georgiadis, Antoine Dufour, Daniel Young, Sean E. Gill, Sameeksha Chopra and Luiz G. Almeida and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Nature Communications.

In The Last Decade

Laurent Devel

42 papers receiving 1.4k citations

Hit Papers

Matrix Metalloproteinases: From Molecular Mechanisms to P... 2022 2026 2023 2024 2022 100 200 300

Peers

Laurent Devel
Hui Cong China
Fernando Doñate United States
Eric B. Springman United States
Quintin Pan United States
Hui Cong China
Laurent Devel
Citations per year, relative to Laurent Devel Laurent Devel (= 1×) peers Hui Cong

Countries citing papers authored by Laurent Devel

Since Specialization
Citations

This map shows the geographic impact of Laurent Devel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laurent Devel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laurent Devel more than expected).

Fields of papers citing papers by Laurent Devel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laurent Devel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laurent Devel. The network helps show where Laurent Devel may publish in the future.

Co-authorship network of co-authors of Laurent Devel

This figure shows the co-authorship network connecting the top 25 collaborators of Laurent Devel. A scholar is included among the top collaborators of Laurent Devel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laurent Devel. Laurent Devel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wamba, Brice E. N., Tanmoy Mondal, Daniel Bedinger, et al.. (2025). Evolutionary regulation of human Fas ligand (CD95L) by plasmin in solid cancer immunotherapy. Nature Communications. 16(1). 5748–5748. 1 indexed citations
2.
Devel, Laurent, Robert Thaï, Lucie Poupel, et al.. (2023). Targeted delivery of LXR-agonists to atherosclerotic lesions mediated by polydiacetylene micelles. Nanoscale. 15(46). 18864–18870. 4 indexed citations
3.
Malgorn, Carole, François Bécher, Carole Fruchart‐Gaillard, et al.. (2023). A New Affinity-Based Probe to Profile MMP Active Forms. Methods in molecular biology. 2747. 29–39.
4.
Almeida, Luiz G., Sameeksha Chopra, Daniel Young, et al.. (2022). Matrix Metalloproteinases: From Molecular Mechanisms to Physiology, Pathophysiology, and Pharmacology. Pharmacological Reviews. 74(3). 714–770. 312 indexed citations breakdown →
5.
Kamińska, M., Carole Malgorn, Carole Fruchart‐Gaillard, et al.. (2021). Ligand‐Directed Modification of Active Matrix Metalloproteases: Activity‐based Probes with no Photolabile Group. Angewandte Chemie International Edition. 60(33). 18272–18279. 14 indexed citations
6.
Kamińska, M., Carole Malgorn, Carole Fruchart‐Gaillard, et al.. (2021). Ligand‐Directed Modification of Active Matrix Metalloproteases: Activity‐based Probes with no Photolabile Group. Angewandte Chemie. 133(33). 18420–18427. 1 indexed citations
7.
Devel, Laurent, Gunter Almer, Claudia Cabella, et al.. (2019). Biodistribution of Nanostructured Lipid Carriers in Mice Atherosclerotic Model. Molecules. 24(19). 3499–3499. 13 indexed citations
8.
Toczek, Jakub, Kiran Gona, Hye-Yeong Kim, et al.. (2019). Novel Matrix Metalloproteinase 12 Selective Radiotracers for Vascular Molecular Imaging. Journal of Medicinal Chemistry. 62(21). 9743–9752. 13 indexed citations
9.
Razavian, Mahmoud, Dimitris Georgiadis, Fabrice Beau, et al.. (2016). Optical imaging of MMP-12 active form in inflammation and aneurysm. Scientific Reports. 6(1). 38345–38345. 22 indexed citations
10.
Kalyva, Maria, Alexandros L. Zografos, Laurent Devel, et al.. (2015). Probing the Mechanism of Allylic Substitution of Morita–Baylis–Hillman Acetates (MBHAs) by using the Silyl Phosphonite Paradigm: Scope and Applications of a Versatile Transformation. Chemistry - A European Journal. 21(8). 3278–3289. 15 indexed citations
11.
Antoni, Claudia, Laura Vera, Laurent Devel, et al.. (2013). Crystallization of bi-functional ligand protein complexes. Journal of Structural Biology. 182(3). 246–254. 49 indexed citations
12.
Devel, Laurent, Fabrice Beau, Laura Vera, et al.. (2012). Simple Pseudo-dipeptides with a P2′ Glutamate. Journal of Biological Chemistry. 287(32). 26647–26656. 31 indexed citations
13.
Bregant, Sarah, Laurent Devel, Marko Novinec, et al.. (2012). A Novel Photoaffinity‐Based Probe for Selective Detection of Cathepsin L Active Form. ChemBioChem. 13(17). 2616–2621. 9 indexed citations
14.
Devel, Laurent, Bertrand Czarny, Fabrice Beau, et al.. (2010). Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1′ cavity. Biochimie. 92(11). 1501–1508. 75 indexed citations
15.
Dabert-Gay, Anne-Sophie, Bertrand Czarny, Laurent Devel, et al.. (2008). Molecular Determinants of Matrix Metalloproteinase-12 Covalent Modification by a Photoaffinity Probe. Journal of Biological Chemistry. 283(45). 31058–31067. 27 indexed citations
16.
Steer, David L., Sarah Bregant, Laurent Devel, et al.. (2007). Cross‐Linking Yield Variation of a Potent Matrix Metalloproteinase Photoaffinity Probe and Consequences for Functional Proteomics. Angewandte Chemie International Edition. 46(18). 3275–3277. 38 indexed citations
17.
Defamie, Virginie, Damiano Patrono, Laurent Devel, et al.. (2007). Matrix metalloproteinase inhibition protects rat livers from prolonged cold ischemia–warm reperfusion injury. Hepatology. 47(1). 177–185. 44 indexed citations
18.
Cuniasse, Philippe, Laurent Devel, Anastasios Makaritis, et al.. (2004). Future challenges facing the development of specific active-site-directed synthetic inhibitors of MMPs. Biochimie. 87(3-4). 393–402. 103 indexed citations
19.
Devel, Laurent, et al.. (2003). Synthesis of protected 2-amino-2-deoxy-d-xylothionolactam derivatives and some aspects of their reactivity. Carbohydrate Research. 338(15). 1591–1601. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026